The Acne Vulgaris Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Acne Vulgaris market has experienced significant growth in the past, with the market size set to increase from $7.94 billion in 2024 to $8.47 billion in 2025. This corresponds to a compound annual growth rate (CAGR) of 6.7%.
The Acne Vulgaris Global Market Report 2025 anticipates that by 2029, the market will reach a size of $10.89 billion. This growth is expected to occur at a Compound Annual Growth Rate (CAGR) of 6.5%.
Download Your Free Sample of the 2025 Acne Vulgaris Market Report and Uncover Key Trends Now!The key drivers in the acne vulgaris market are:
• Growing awareness of skincare and emphasis on self-care and wellness
• Increase in the teenage population and rising incidence of adult acne
• Expansion and development in telemedicine services
• E-commerce growth and the surge in online retail platforms for skincare products
The acne vulgaris market covered in this report is segmented –
1) By Type: Systemic Therapy, Hormonal Therapy, Physical Treatment, Topical Combination Therapy, Other Types
2) By Age Group: 10 To 17 Years, 18 To 44 Years, 45 To 64 Years, 65 Years And Above
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Systemic Therapy: Oral Antibiotics, Oral Retinoids, Oral Anti-Inflammatory Agents
2) By Hormonal Therapy: Oral Contraceptives, Androgen Receptor Inhibitors
3) By Physical Treatment: Laser Therapy, Light-Based Therapy, Chemical Peels, Microdermabrasion
4) By Topical Combination Therapy: Retinoid And Antibiotic Combinations, Benzoyl Peroxide And Antibiotic Combinations, Retinoid And Benzoyl Peroxide Combinations
5) By Other Types: Herbal And Natural Remedies, Biologic Therapies, Emerging Therapies
The key trends in the acne vulgaris market are:
• Technological advancements are shaping the acne vulgaris market future.
• The market future stands to be greatly influenced by the innovative product launches.
• The trend of gaining clinical approval has a notable contribution to the market.
• There is a rise in the innovations of novel medical processes.
Major players in the acne vulgaris market are:
• Pfizer Inc.
• Johnson and Johnson
• AbbVie Inc.
• L'Oréal Paris
• GlaxoSmithKline Plc.
• Reckitt Benckiser Group plc
• Viatris Inc.
• Teva Pharmaceuticals
• Bausch Healh Companies
• Sun Pharmaceutical Industries Ltd.
• Incyte
• Aurobindo Pharma
• Lupin Ltd.
• Torrent Pharmaceuticals
• Biocon
• Stiefel Laboratories
• Mayne Pharma Group Limited
• Paratek Pharmaceuticals
• Cosmo Pharmaceuticals
• AOBiome
North America was the largest region in the acne vulgaris market in 2024